68 related articles for article (PubMed ID: 843724)
1. Inhibition of substance P release from the isolated rat substantia nigra by GABA [proceedings].
Jessell TM; Iversen LL
Br J Pharmacol; 1977 Mar; 59(3):486P. PubMed ID: 843724
[No Abstract] [Full Text] [Related]
2. Regulation of GABA release by dopamine in the rat substantia nigra.
Reubi JC; Iversen LL; Jessell TM
Adv Biochem Psychopharmacol; 1978; 19():401-4. PubMed ID: 696468
[No Abstract] [Full Text] [Related]
3. The behavioural effects of EOS-induced changes in substantia nigra GABA levels [proceedings].
Koob G; del Fiacco M; Iversen SD
Br J Pharmacol; 1976 Nov; 58(3):454P. PubMed ID: 990632
[No Abstract] [Full Text] [Related]
4. Substance P release from the rat substantia nigra.
Jessell TM
Brain Res; 1978 Aug; 151(3):469-78. PubMed ID: 667625
[TBL] [Abstract][Full Text] [Related]
5. A behavioural model of the GABA-facilitating action of benzodiazepines: rotational behaviour after unilateral intranigral injection of chloridiazepoxide [proceedings].
Waddington JL; Crow TJ
Br J Pharmacol; 1976 Nov; 58(3):453P. PubMed ID: 990631
[No Abstract] [Full Text] [Related]
6. Effects of GABA and L-glutamic acid on the potassium-evoked in vitro release of substance P- and neurokinin A-like immunoreactivities are different in the rat striatum and substantia nigra.
Humpel C; Saria A
Neurosci Lett; 1989 Oct; 105(1-2):159-63. PubMed ID: 2484728
[TBL] [Abstract][Full Text] [Related]
7. Potentiation of gamma-aminobutyric acid (GABA) action by inhibiting neuroglial uptake [proceedings].
Galvan M; Brown DA
Br J Pharmacol; 1977 Mar; 59(3):485P-486P. PubMed ID: 843723
[No Abstract] [Full Text] [Related]
8. Inhibition of dopaminergic activity in the extrapyramidal and limbic systems by gamma-acetylenic GABA [proceedings].
Huot S; Lippert B; Palfreyman MG; Schechter PJ
Br J Pharmacol; 1977 Jun; 60(2):264P-265P. PubMed ID: 880435
[No Abstract] [Full Text] [Related]
9. Synaptosomal uptake and release of dopamine in substantia nigra: effects of gamma-aminobutyric acid and substance P.
Silbergeld EK; Walters JR
Neurosci Lett; 1979 Apr; 12(1):119-26. PubMed ID: 460694
[TBL] [Abstract][Full Text] [Related]
10. In vivo release of endogenous GABA from rat substantia nigra measured by a novel method.
Van der Heyden JA; Venema K; Korf J
J Neurochem; 1979 Feb; 32(2):469-76. PubMed ID: 762559
[No Abstract] [Full Text] [Related]
11. Proceedings: Topographical study of the distribution of GABA in the human substantia nigra.
Kanazawa I; Kelly JS
Br J Pharmacol; 1975 Oct; 55(2):309P. PubMed ID: 1201435
[No Abstract] [Full Text] [Related]
12. Modulation of methylenedioxymethamphetamine-induced striatal dopamine release by the interaction between serotonin and gamma-aminobutyric acid in the substantia nigra.
Yamamoto BK; Nash JF; Gudelsky GA
J Pharmacol Exp Ther; 1995 Jun; 273(3):1063-70. PubMed ID: 7791076
[TBL] [Abstract][Full Text] [Related]
13. GABAergic mechanisms in regulating the activity state of substantia nigra pars reticulata neurons.
Windels F; Kiyatkin EA
Neuroscience; 2006 Jul; 140(4):1289-99. PubMed ID: 16713116
[TBL] [Abstract][Full Text] [Related]
14. GABA(B) receptor activation inhibits dopamine D1 receptor-mediated facilitation of [(3)H]GABA release in substantia nigra pars reticulata.
Nava-Asbell C; Paz-Bermudez F; Erlij D; Aceves J; Florán B
Neuropharmacology; 2007 Oct; 53(5):631-7. PubMed ID: 17868750
[TBL] [Abstract][Full Text] [Related]
15. Progabide reverses the nigral substance P reduction induced by chronic impairment of dopaminergic transmission.
Zivkovic B; Oblin A; Bartholini G
Eur J Pharmacol; 1985 Jun; 112(2):253-5. PubMed ID: 2411575
[TBL] [Abstract][Full Text] [Related]
16. GABA inhibition of 3H-glycine release from slices of rat substantia nigra in vitro.
Kerwin R; Pycock C
Eur J Pharmacol; 1980 Jun; 64(2-3):169-72. PubMed ID: 7398760
[TBL] [Abstract][Full Text] [Related]
17. Dopamine selectively increases 3H-GABA release from slices of rat substantia nigra in vitro.
Reubi JC; Iversen LL; Jessell TM
Nature; 1977 Aug; 268(5621):652-4. PubMed ID: 197423
[No Abstract] [Full Text] [Related]
18. Changes of amino acid and monoamine levels after neonatal 6-hydroxydopamine denervation in rat basal ganglia, substantia nigra, and Raphe nuclei.
Molina-Holgado E; Dewar KM; Grondin L; van Gelder NM; Reader TA
J Neurosci Res; 1993 Jul; 35(4):409-18. PubMed ID: 8360949
[TBL] [Abstract][Full Text] [Related]
19. GABA-potentiating action of pentobarbitone on the isolated superior cervical ganglion of the rat [proceedings].
Evans RH
J Physiol; 1977 Oct; 272(1):49P-50P. PubMed ID: 592147
[No Abstract] [Full Text] [Related]
20. Modulation of GABA release by dopamine in the substantia nigra.
Matuszewich L; Yamamoto BK
Synapse; 1999 Apr; 32(1):29-36. PubMed ID: 10188635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
